Brief: Oncoarendi Therapeutics Q3 Net Loss Widens To 1.9 Mln Zlotys

Molecure SA

29/10/2021 06:21

Oct 29 (Reuters) - Oncoarendi Therapeutics SA  OAT.WA :
    * REPORTS Q3 NET LOSS OF 1.9 MILLION ZLOTYS VERSUS LOSS OF
0.8
MILLION ZLOTYS YEAR AGO
    * Q3 OPERATING REVENUE 0.1 MILLION ZLOTYS VERSUS 629 ZLOTYS
YEAR
AGO
    * Q3 REVENUE FROM SUBSIDIES AT 0.2 MILLION ZLOTYS VERSUS 0.4
MILLION ZLOTYS YEAR AGO 
    * Q3 OPERATING LOSS OF 1.9 MILLION ZLOTYS VERSUS LOSS OF 0.8
MILLION ZLOTYS YEAR AGO

    
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nEM6m59Lqa
 Further company coverage:  OAT.WA  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))